Researchers examine the impact of cognitive behavioral therapy (CBT) on lifestyle changes among type 2 diabetes and obesity patients.
HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities | Psychedelic Invest
VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the